Evidence mapPaperPMID 39769451Full record

ArticleInternational journal of molecular sciences2024

Multi-Objective Optimization Accelerates the De Novo Design of Antimicrobial Peptide for

Cheng-Hong Yang, Yi-Ling Chen, Tin-Ho Cheung, Li-Yeh Chuang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cheng-Hong YangDepartment of Electronic Engineering, National Kaohsiung University of Science and Technology, Kaohsiung 807618, Taiwan.ORCID 0000-0002-2741-0072
Yi-Ling ChenDepartment of Electronic Engineering, National Kaohsiung University of Science and Technology, Kaohsiung 807618, Taiwan.ORCID 0009-0007-4017-0740
Tin-Ho CheungDepartment of Electronic Engineering, National Kaohsiung University of Science and Technology, Kaohsiung 807618, Taiwan.ORCID 0009-0001-9489-8303
Li-Yeh ChuangDepartment of Chemical Engineering & Institute of Biotechnology Engineering and Chemical Engineering, I-Shou University, Kaohsiung 824005, Taiwan.ORCID 0000-0002-9817-5102

Funding

MInistry of Science and Technology, Taiwan 111-2221-E-165-001-MY3
6 · The paper itself

Abstract

Humans have long used antibiotics to fight bacteria, but increasing drug resistance has reduced their effectiveness. Antimicrobial peptides (AMPs) are a promising alternative with natural broad-spectrum activity against bacteria and viruses. However, their instability and hemolysis limit their medical use, making the design and improvement of AMPs a key research focus. Designing antimicrobial peptides with multiple desired properties using machine learning is still challenging, especially with limited data. This study utilized a multi-objective optimization method, the non-dominated sorting genetic algorithm II (NSGA-II), to enhance the physicochemical properties of peptide sequences and identify those with improved antimicrobial activity. Combining NSGA-II with neural networks, the approach efficiently identified promising AMP candidates and accurately predicted their antibacterial effectiveness. This method significantly advances by optimizing factors like hydrophobicity, instability index, and aliphatic index to improve peptide stability. It offers a more efficient way to address the limitations of AMPs, paving the way for the development of safer and more effective antimicrobial treatments.

Indexed as

Antimicrobial PeptidesStaphylococcus aureusAlgorithmsAmino Acid SequenceAnti-Bacterial AgentsAntimicrobial Cationic PeptidesDrug DesignHumansHydrophobic and Hydrophilic InteractionsMachine LearningMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial Peptidesantimicrobial peptidemulti-objective optimizationphysicochemical propertiesStaphylococcus aureus

Identifiers

PMID39769451
PMCPMC11728188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.